SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM by Birdie Huang, Chieh-Li Yen, Chao-Yi Wu, Chung-Ying Tsai, Jia-Jin Chen, Ching-Chung Hsiao, Yung-Chang Chen, I-Chang Hsieh, Huang-Yu Yang

Get full text

Author Correction: SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM by Birdie Huang, Chieh-Li Yen, Chao-Yi Wu, Chung-Ying Tsai, Jia-Jin Chen, Ching-Chung Hsiao, Yung-Chang Chen, I-Chang Hsieh, Huang-Yu Yang

Get full text

Prognostic significance of clonal hematopoiesis in STEMI: a 10-year follow-up reveals high-risk gene mutations by Wen-Lang Fan, Jih-Kai Yeh, Li-Ching Hsieh, Ming-Lung Tsai, Ming-Yun Ho, Yi-Chun Huang, I-Chang Hsieh, Ming-Shien Wen, Chao-Yung Wang

Get full text

Cardiac power output associated with hospitalization and mortality in coronary artery disease patients at stage B heart failure by Ming-Jer Hsieh, Jih-Kai Yeh, Yu-Chang Huang, Ming-Yun Ho, Dong-Yi Chen, Cheng-Hung Lee, Chao-Yung Wang, Shang-Hung Chang, Chun-Chi Chen, I-Chang Hsieh

Get full text

Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan by Kuan-Chieh Tu, Wei-Ting Chang, Hui-Wen Lin, Po-Lin Lin, Yen-Wen Wu, Chao-Feng Lin, Hung-I. Yeh, Min-Ji Charng, Po-Hsun Huang, Tsung-Hsien Lin, Wei-Wen Lin, I.-Chang Hsieh, Feng-Yu Kuo, Ching-Pei Chen, Sheng-Hsiang Lin, Yi-Heng Li

Get full text

2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region by Jack WC Tan, Derek P Chew, Muhamad Ali SK Abdul Kader, Junya Ako, Vinay K Bahl, Mark Chan, Kyung Woo Park, Praveen Chandra, I-Chang Hsieh, Do Quang Huan, Sofian Johar, Dafsah Arifa Juzar, Byeong-Keuk Kim, Cheol Whan Lee, Michael Kang-Yin Lee, Yi-Heng Li, Wael Almahmeed, Eric Oliver Sison, Doreen Tan, Yu-Chen Wang, Shiuan Jong Yeh, Gilles Montalescot

Get full text